OllieDX | AI-Powered Neurodevelopmental and Mental Healthcare Ecosystem

OllieDX: An AI-Powered Neurodevelopmental and Mental Healthcare Ecosystem

Our Vision

OllieDX is developing a connected healthcare ecosystem bringing together individuals, families, clinicians and specialist providers on one digital platform. We aim to support the journey from early screening and assessment to referrals, care coordination and ongoing support.

ADHD is our initial clinical focus. Our wider roadmap includes autism, dyslexia, anxiety, depression, OCD, PTSD and related conditions, with each clinical function subject to appropriate validation and regulatory review.

The Challenge

People seeking neurodevelopmental or mental healthcare often navigate disconnected services, repeated forms, long referral processes and fragmented communications. Clinics and professionals manage questionnaires, assessment tools, appointments and reports across separate systems.

OllieDX aims to simplify these processes while preserving professional judgement and clinical accountability.

The OllieDX Ecosystem

Digital Screening: Structured questionnaires and digital tools help people recognise potential concerns and identify appropriate next steps. Screening does not constitute a diagnosis.

Multimodal AI Assessment: Our proposed technology combines Continuous Performance Testing (CPT), eye tracking, motion tracking, natural language processing and structured questionnaires to organise assessment findings for qualified clinicians.

Healthcare Professional Network: A directory helps individuals find independent practitioners, specialist clinics and relevant services, with clearer information on specialities, appointments and referral routes.

Clinical Workflow Management: Planned capabilities include patient onboarding, bookings, assessment coordination, secure communication, clinical report workflows and follow-up management.

Care Navigation: A connected pathway is intended to support people and families from initial enquiries through specialist review, referrals and ongoing support.

Responsible AI and Governance: Our development approach addresses data protection, cybersecurity, human oversight, model evaluation, bias monitoring, clinical safety and controlled software updates.

Who It Is For

OllieDX is designed for individuals and families, independent clinicians, specialist clinics, NHS and private healthcare organisations, and potential academic and research collaborators.

Technology and Regulatory Approach

We are building a modular, cloud-based platform integrating patient services, clinical workflows and AI assessment components. This approach is intended to support new specialities and deployment settings without creating separate systems for every service.

AI outputs are intended to assist, not replace, qualified clinical professionals. Each medical function will require suitable clinical evidence, assessment of its intended purpose and compliance with applicable UK medical-device and data-protection requirements before clinical deployment.

Commercial Opportunity

We are exploring subscriptions for healthcare providers, clinic workflow software, licensing of validated assessment tools and integration partnerships. The UK is our initial target market, with international opportunities considered subject to local requirements.

What Makes OllieDX Different

We are not building a standalone ADHD questionnaire. OllieDX brings together digital screening, multimodal assessment support, independent specialist access, practice workflows and care navigation within one ecosystem. Our aim is to reduce fragmentation, support more efficient service delivery and help professionals access relevant assessment information in one place.

Partnerships We Seek

We welcome discussions with NHS organisations, private providers, neurodevelopmental specialists, universities, researchers, technology partners and investors.

We are particularly interested in clinical validation, pilot studies, healthcare integrations, regulatory guidance, product development and commercial partnerships. Together with suitable partners, we aim to evaluate whether a connected AI-enabled approach improves the assessment experience and supports safe, efficient care.

Website: https://olliedx.com